Volume 21 - Issue 1 - January, 2009

Microbial Cellulose Wound Dressing in the Treatment of Nonhealing Lower Extremity Ulcers

Abstract: Following standard care, nonhealing lower extremity (LE) ulcers were managed with a bacterial cellulose (BC) wound dressing, Dermafill™, (AMD/Ritmed, Tonawanda, NY), derived from Acetobacter xylinum. The time to 75% reduction in wound size was compared in 11 chronic wounds before and after the application of BC. The mean period of observation before the application of BC was 315 days; (95% CI: 239–392 days). With the application of BC to these chronic wounds, the mean time to 75% epithelization was reduced to 81 days (95% CI: 50–111 days) with a median of 79 days. The ra



Infected Venous Leg Ulcers: Management With Silver-releasing Foam Dressing

Abstract: The aim of this work was to study the safety and effectiveness of silver foam dressing (Contreet® Ag, Coloplast, Humlebaek, Denmark) in promoting the healing of infected venous ulcers over 9 weeks of treatment. Forty-two patients with infected venous ulcers were included and randomized into two groups. Group A had 21 patients (12 women and 9 men, mean age 61.2 years) who were treated with the silver foam for 9 weeks. Group B also had 21 patients (14 women and 7 men, mean age 58.7 years) who were treated with a nonadhesive foam (Biatain®, Coloplast, Humlebaek, Denmark) for 9



Comparing Advanced Wound Technologies

     The authors randomized 42 patients with venous stasis ulcers who were divided to receive either a nonadherent silver-based foam dressing or a nonadherent foam. The authors reported faster healing in the silver foam group. The authors are to be commended on comparing newer, “advanced” wound technologies in a randomized trial. The vast majority of trials seem to compare an “advanced” method to moist gauze. Additionally, there are added complexities in performing a randomized clinical study.

     Despite these accolades, there are many issues with th



Hemicellulose Dressing for Skin Lesions Caused by Herpes Zoster in a Patient With Leukemia—An Alternative Dressing

Abstract: Herpes zoster is a painful disease that can develop in immunosuppressed children. Prolonged immunosuppression in leukemia patients can substantially delay healing of herpetic lesions. The purpose of this report was to evaluate the use of hemicellulose dressings as an alternative treatment for extensive herpetic lesions in an immunosuppressed child with leukemia. The hemicellulose dressing was applied to the lesions on the second day after debridement. After 36 days, the lesions were completely healed. The hemicellulose dressing was an effective resource for promoting complete



Cadexomer Iodine: An Effective Palliative Dressing in Chronic Critical Limb Ischemia

Abstract: Cadexomer iodine (CI) was evaluated as a palliative wound care dressing for foot ulcers in chronic critical limb ischemia (CCLI) given its ability to prevent infection and absorb moisture. Methods. A retrospective study of 11 patients with CCLI and wounds on distal lower extremities that were treated with cadexomer iodine. The product was applied topically on a daily basis. Wounds were debrided cautiously to minimize blood loss. Patients were monitored in the clinic on a weekly to biweekly basis. Results. Seven patients in this cohort had all or some wounds on their feet close



Change Can Be Good For Your Patients

Dear Readers,

     Change—have you heard enough about that lately? Everywhere we turn we are blasted by the message that we need change. Unfortunately, we are told little about what we need to change; we just need to change to something different. Many times the decision as to whether the change is good or bad depends on who is recommending the change! In medicine and especially wound care, change can be good if improvement in patient care and outcomes is achieved.

     Unfortunately, change in medicine is slow. Many people resist change, some for no reaso



Industry News

ConvaTec Acquires Exclusive Rights for NPWT System

     ConvaTec (Skillman, NJ) recently signed a long-term global exclusive license agreement with Boehringer Technologies (Ridgefield, Conn) to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.

     Boehringer’s NPWT System was first launched in 2007 and is both a technology and engineering solution that utilizes the application of negative pressure to a wound to promote healing by creating controlled tissue



New Products

New V.A.C.® Simplace™ Dressing Features, V.A.C.® GranuFoam™ and 3M™ Tegaderm™ Dressings

     Kinetic Concepts Inc (San Antonio, Tex) announced the launch of its new V.A.C.® Simplace™ dressing that features both a newly designed V.A.C.® GranuFoam™ dressing and a 3M™ Tegaderm™ dressing designed exclusively for use with KCI’s proprietary V.A.C.® Therapy System. The design of the new dressings makes the dressing changing process easier, faster, and more intuitive to apply.

     Several new features are incorporated into the new dr